Search for stocks /

Shri Ahimsa Naturals Q1FY26 concall decoded: – Caffeine highs, Margin jitters & NSE debut

Opening Hook
Forget your morning espresso—Shri Ahimsa is bottling caffeine at industrial scale. Fresh from its NSE Emerge debut (Aug 2025), the company reported FY25 revenue of ₹9,581 lakh, up 23% YoY, with PAT of ₹2,190 lakh (Investor Presentation, Aug 24, 2025). Sounds stimulating, but EBITDA margins fell from 50.5% in FY23 to 33.7% in FY25—proof that even natural caffeine can get diluted. Why it matters now? Because the world’s shift to “natural & premium” labels is growing, and Shri Ahimsa sits at the sweet spot of coffee waste alchemy. Whether it can keep margins awake while scaling 3x capacity will decide if this is the real buzz or just another energy drink crash.

At a Glance
• Revenue ₹9,581 lakh – up 23% YoY; demand brewing well
• EBITDA ₹3,226 lakh – up 18% YoY; margins squeezed from ~50% to ~34%
• PAT ₹2,190 lakh – up 17% YoY; EPS ₹11.6 vs ₹10.2
• Net worth ₹15,455 lakh – nearly doubled on IPO proceeds
• Net debt-free – from ₹1,383 lakh debt in FY24 to ₹30 lakh in FY25
• ROCE ~26% – still healthy, though down from FY23’s caffeine peak

Management’s Key Commentary
“Both revenue and PAT grew double digits in FY25.” → Translation: topline buzz, but margin hangover.
“We’re now net-debt free post-IPO.” → Translation: caffeine-fueled balance sheet detox.
“Construction of greenfield expansion has begun.” → Translation: brewing 3x more capacity, hoping demand keeps pace.
“Received FSSC 22000 approval.” → Translation: yes, we’re officially safe to sip.
“India’s GDP growth and export markets will support future volumes.” → Translation: global insomnia is our TAM.
“Waste-to-value initiatives like extracting caffeine from coffee wax and sludge.” → Translation: turning your filter kaachra into gold dust.

Numbers Decoded

MetricThe HeroOne-liner
Revenue – The Hero₹9,581 lakhUp 23% YoY; driven by caffeine exports.
EBITDA – The Sidekick₹3,226 lakhMargins slipped to 34%; competition & scaling costs brewing.
Margins – The Drama QueenPAT ₹2,190 lakhYoY growth, but far below FY23’s ₹3,821 lakh peak; EPS halved from IPO-year highs.

Analyst Questions
Q: Margins down from 50% to ~34%—why?
A: “Imports, raw material

error: Content is protected !!